Acute myeloid leukaemia (AML) is a malignant blood disorder comprising uncontrolled proliferation of myeloid blasts 1. AML is a genetically heterogeneous disease; however, its physical symptoms are ...
BERLIN, GERMANY, September 25, 2018 - Myelo Therapeutics GmbH announced today that the US Food and Drug Administration (FDA) has granted an Orphan Drug Designation to its orally applied new chemical ...
STUDIO CITY, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is proud to announce the launching of Myelo—the first AI-powered responsive chatbot designed to act ...
Myeloma, also known as multiple myeloma, is a cancer that develops in the bone marrow when plasma cells grow out of control, potentially damaging bones, weakening the immune system, and causing.
The issuer is solely responsible for the content of this announcement. Berlin, 21 July 2022. Myelo Therapeutics GmbH, an Affiliate of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN ...
The MarketWatch News Department was not involved in the creation of this content. International Myeloma Foundation Launches Myelo: The First AI-Powered Responsive Chatbot to Provide Compassionate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results